Business Description
![Replimune Group Inc Replimune Group Inc logo](https://static.gurufocus.com/logos/0C0000BHIM.png?14)
Replimune Group Inc
NAICS : 325412
SIC : 2834
ISIN : US76029N1063
Description
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.55 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.2 | |||||
Debt-to-EBITDA | -0.37 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -23.5 | |||||
3-Year EPS without NRI Growth Rate | -27.1 | |||||
3-Year FCF Growth Rate | -27.7 | |||||
3-Year Book Growth Rate | -17.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 23.25 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 88.51 | |||||
9-Day RSI | 79.11 | |||||
14-Day RSI | 73.25 | |||||
6-1 Month Momentum % | 4.56 | |||||
12-1 Month Momentum % | -59.51 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.72 | |||||
Quick Ratio | 10.72 | |||||
Cash Ratio | 10.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.7 | |||||
Shareholder Yield % | -3.22 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -46.3 | |||||
ROA % | -38.08 | |||||
ROIC % | -331.29 | |||||
ROC (Joel Greenblatt) % | -400.74 | |||||
ROCE % | -39.4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.74 | |||||
Price-to-Tangible-Book | 1.74 | |||||
EV-to-EBIT | -1.6 | |||||
EV-to-EBITDA | -1.62 | |||||
EV-to-Forward-Revenue | 12.55 | |||||
EV-to-FCF | -1.75 | |||||
Price-to-Net-Current-Asset-Value | 2.13 | |||||
Price-to-Net-Cash | 2.21 | |||||
Earnings Yield (Greenblatt) % | -62.5 | |||||
FCF Yield % | -29.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:REPL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Replimune Group Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -3.24 | ||
Beta | 0.47 | ||
Volatility % | 89.84 | ||
14-Day RSI | 73.25 | ||
14-Day ATR ($) | 0.683671 | ||
20-Day SMA ($) | 8.8935 | ||
12-1 Month Momentum % | -59.51 | ||
52-Week Range ($) | 4.92 - 22.21 | ||
Shares Outstanding (Mil) | 61.42 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Replimune Group Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Replimune Group Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Replimune Group Inc Frequently Asked Questions
What is Replimune Group Inc(REPL)'s stock price today?
The current price of REPL is $10.61. The 52 week high of REPL is $22.21 and 52 week low is $4.92.
When is next earnings date of Replimune Group Inc(REPL)?
The next earnings date of Replimune Group Inc(REPL) is 2024-08-02 Est..
Does Replimune Group Inc(REPL) pay dividends? If so, how much?
Replimune Group Inc(REPL) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |